2019
DOI: 10.1016/j.freeradbiomed.2019.03.034
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers of oxidative stress in the fetus and in the newborn

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
47
0
3

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
2
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 48 publications
(50 citation statements)
references
References 88 publications
0
47
0
3
Order By: Relevance
“…As there is not yet a well-established oxygen saturation target and the cut-off value for surfactant treatment may be arbitrary, these patients may receive higher oxygen content. This can trigger the activation of pro-inflammatory and pro-apoptotic pathways, which may contribute to bronchopulmonary dysplasia and other pathologies [30] before surfactant treatment is given during the first hours of life. By contrast, basing the surfactant treatment on LUS score seems to decrease the maximal FiO 2 and the duration of oxygen treatment and may help to decrease oxygen toxicity.…”
Section: Discussionmentioning
confidence: 99%
“…As there is not yet a well-established oxygen saturation target and the cut-off value for surfactant treatment may be arbitrary, these patients may receive higher oxygen content. This can trigger the activation of pro-inflammatory and pro-apoptotic pathways, which may contribute to bronchopulmonary dysplasia and other pathologies [30] before surfactant treatment is given during the first hours of life. By contrast, basing the surfactant treatment on LUS score seems to decrease the maximal FiO 2 and the duration of oxygen treatment and may help to decrease oxygen toxicity.…”
Section: Discussionmentioning
confidence: 99%
“…The negative economic impacts on health systems resulted from the treatment of these diseases, stimulating the development of new, cheaper, and more effective therapeutic alternatives [2]. A key factor involved in the development and progression of many chronic diseases is the oxidative stress [3], which is caused by endogenous (deregulation in the body's redox balance) [4] and exogenous (environmental agents) factors [5]. At low concentrations, reactive species (RS) are physiologically important and participate in cellular signaling of biochemical and immunological processes [6].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, premature infants are especially prone to oxidant injury, in various organs and systems [17][18][19]. The short-term effects of hyperoxia on lungs determines: alterations of the lung epithelium and activation of surfactant with alveolar edema, interstitial thickening, brosis, atelectasis; on retina: activation of various transcription factors including HIF-1α and VEGF, responsible, in a rst phase, of the cessation of retinal vascular growth and subsequently of the abnormal proliferation of retinal vessels with the formation of intraretinal ridges, responsible of the increased risk of retinal detachment; on erythrocytes: oxidative hemolysis and anemia [2]. The long-term effects are described in clinical and experimental studies.…”
Section: Discussionmentioning
confidence: 99%
“…Oxygen toxicity is due to the development of reactive oxygen species (ROS), potent oxidants in biological uids that may damage tissues, through reaction with lipids, proteins, DNA, amino acids and several other molecules [1]. An imbalance between oxidants and antioxidants is called oxidative stress: a potential cause of cell damage [2]. Newborns, especially if preterm, are particular susceptible to oxidative stress due to the immature antioxidant capacity and the likely exposure to many processes such as hypoxia, hypoxia-ischemia, hyperoxia and infections, leading to high levels of free radicals' production [3].…”
Section: Introductionmentioning
confidence: 99%